Cambridge Ion Channel Forum Barry Cross Conference Centre, Babraham Research Campus, Cambridge CB22 3AT
Programme
6 November 2014
12.00
Registration with lunch
13.15
Welcome
13.20
Neurons calling: neurons regulate OPCs differentiation in health and disease Thora K谩rad贸ttir, University of Cambridge
14.20
Novel proof of concept studies demonstrated the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia and lumbosacral radiculopathy Valerie Morisset, Convergence Pharmaceuticals
14.55
Refreshments
15.30
The P2X4 receptor for ATP: function and pharmacology Sam Fountain, University of East Anglia
16.05
A novel selective and orally bioavailable NaV1.8 blocker PF-01247324 attenuates nociception and sensory neuron excitability Liz Payne, Neusentis
16.40
Ion channels and biologics: potent, selective and mechanistically differentiated Nanobodies targeting KV1.3 Tim Dale, Essen BioScience
17.15
Final comments
17.20
Close